|
Krebs Biochemicals & Industries Ltd.
|
Balance Sheet
|
|
|
You can view the
Balance Sheet
for the last 5 years.
|
Market Cap. (Rs.)
|
153.94 Cr.
|
P/BV
|
-1.55
|
Book Value (Rs.)
|
-46.13
|
|
52 Week High/Low (Rs.)
|
94/59
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
27/09/2023
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| No. of Equity Shares (in Lacs) | 215.60 | 215.60 | 196.20 | 180.00 | 166.30 |
| | | | | | |
| EQUITIES AND LIABILITIES | | | | | |
| SHAREHOLDER'S FUNDS | | | | | |
| Equity Share Capital | 21.56 | 21.56 | 19.62 | 18.00 | 16.63 |
| Preference Share Capital | 130.00 | 130.00 | 0.00 | 0.00 | 0.00 |
| Total Share Capital | 151.56 | 151.56 | 19.62 | 18.00 | 16.63 |
| | | | | | |
| Reserves and Surplus | -121.02 | -96.65 | -66.52 | -50.65 | -30.92 |
| Total Reserves and Surplus | -121.02 | -96.65 | -66.52 | -50.65 | -30.92 |
| Money Received Against Share Warrants | 0.00 | 0.00 | 4.17 | 7.65 | 0.00 |
| Total Shareholders Funds | 30.54 | 54.91 | -42.73 | -25.00 | -14.29 |
| | | | | | |
| NON-CURRENT LIABILITIES | | | | | |
| Long Term Borrowings | 43.25 | 2.93 | 100.55 | 65.51 | 50.23 |
| Other Long Term Liabilities | 51.79 | 53.60 | 52.71 | 49.69 | 49.29 |
| Long Term Provisions | 0.31 | 0.30 | 0.50 | 0.47 | 2.27 |
| Total Non-Current Liabilities | 95.34 | 56.83 | 153.76 | 115.66 | 101.79 |
| | | | | | |
| CURRENT LIABILITIES | | | | | |
| Short Term Borrowings | 9.99 | 9.99 | 0.00 | 0.00 | 0.00 |
| Trade Payables | 15.28 | 37.91 | 20.78 | 22.65 | 21.46 |
| Other Current Liabilities | 23.09 | 29.58 | 26.59 | 19.65 | 32.74 |
| Short Term Provisions | 0.75 | 0.59 | 0.82 | 0.84 | 0.66 |
| Total Current Liabilities | 49.10 | 78.06 | 48.19 | 43.13 | 54.86 |
| | | | | | |
| Total Capital And Liabilities | 174.98 | 189.81 | 159.22 | 133.80 | 142.37 |
| | | | | | |
| ASSETS | | | | | |
| NON-CURRENT ASSETS | | | | | |
| Tangible Assets | 146.47 | 137.69 | 116.26 | 103.37 | 99.08 |
| Intangible Assets | 0.84 | 1.02 | 1.66 | 1.92 | 2.18 |
| Capital Work-In-Progress | 2.24 | 6.53 | 10.09 | 2.35 | 1.63 |
| Intangible Assets Under Development | 1.85 | 1.85 | 1.85 | 1.85 | 1.85 |
| Fixed Assets | 151.40 | 147.09 | 129.86 | 109.48 | 104.75 |
| Other Non-Current Assets | 7.52 | 7.23 | 7.94 | 5.46 | 6.64 |
| Total Non-Current Assets | 158.92 | 154.31 | 137.80 | 114.94 | 111.39 |
| | | | | | |
| | | | | | |
| CURRENT ASSETS | | | | | |
| Inventories | 11.95 | 25.56 | 16.60 | 15.00 | 8.96 |
| Trade Receivables | 0.53 | 0.88 | 0.30 | 0.20 | 2.91 |
| Cash And Cash Equivalents | 0.09 | 0.10 | 0.71 | 0.17 | 17.32 |
| OtherCurrentAssets | 3.50 | 8.95 | 3.81 | 3.49 | 1.78 |
| Total Current Assets | 16.06 | 35.49 | 21.42 | 18.86 | 30.98 |
| | | | | | |
| Total Assets | 174.98 | 189.81 | 159.22 | 133.80 | 142.37 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
| Contingent Liabilities | 5.63 | 5.55 | 5.53 | 4.84 | 5.95 |